145 related articles for article (PubMed ID: 37251320)
1. Canagliflozin alleviates high glucose-induced peritoneal fibrosis via HIF-1α inhibition.
Wang J; Lv X; A-Ni-Wan AS; Tian SS; Wang JM; Liu HY; Fan XG; Zhou SJ; Yu P
Front Pharmacol; 2023; 14():1152611. PubMed ID: 37251320
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of chromatin accessibility and transcriptome landscapes in the induction of peritoneal fibrosis by high glucose.
Song Q; Wang P; Wang H; Pan M; Li X; Yao Z; Wang W; Tang G; Zhou S
J Transl Med; 2024 Mar; 22(1):243. PubMed ID: 38443979
[TBL] [Abstract][Full Text] [Related]
3. STAT3/HIF-1α signaling activation mediates peritoneal fibrosis induced by high glucose.
Yang X; Bao M; Fang Y; Yu X; Ji J; Ding X
J Transl Med; 2021 Jun; 19(1):283. PubMed ID: 34193173
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor-1α promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3.
Baumann B; Hayashida T; Liang X; Schnaper HW
Kidney Int; 2016 Oct; 90(4):797-808. PubMed ID: 27503806
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcylation regulates HIF-1α and induces mesothelial-mesenchymal transition and fibrosis of human peritoneal mesothelial cells.
Wang J; Xin Lv ; Aniwan A; Liu H; Lin Y; Shao X; Zhou S; Yu P
Heliyon; 2023 Dec; 9(12):e22916. PubMed ID: 38144265
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization.
Zhou X; Chen H; Shi Y; Li J; Ma X; Du L; Hu Y; Tao M; Zhong Q; Yan D; Zhuang S; Liu N
Front Immunol; 2023; 14():1137332. PubMed ID: 36911746
[TBL] [Abstract][Full Text] [Related]
7. TGF-β/Smad3 activates mammalian target of rapamycin complex-1 to promote collagen production by increasing HIF-1α expression.
Rozen-Zvi B; Hayashida T; Hubchak SC; Hanna C; Platanias LC; Schnaper HW
Am J Physiol Renal Physiol; 2013 Aug; 305(4):F485-94. PubMed ID: 23761672
[TBL] [Abstract][Full Text] [Related]
8. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
Jiang N; Zhang Z; Shao X; Jing R; Wang C; Fang W; Mou S; Ni Z
J Cell Physiol; 2020 Jan; 235(1):364-379. PubMed ID: 31236971
[TBL] [Abstract][Full Text] [Related]
9. GSK343, an inhibitor of EZH2, mitigates fibrosis and inflammation mediated by HIF-1α in human peritoneal mesothelial cells treated with high glucose.
Wang Q; Xu L; Zhang X; Liu D; Wang R
Eur J Pharmacol; 2020 Aug; 880():173076. PubMed ID: 32222493
[TBL] [Abstract][Full Text] [Related]
10. Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro.
Yang Y; Liu K; Liang Y; Chen Y; Chen Y; Gong Y
Int J Clin Exp Pathol; 2015; 8(3):2746-54. PubMed ID: 26045780
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of EZH2 suppresses peritoneal angiogenesis by targeting a VEGFR2/ERK1/2/HIF-1α-dependent signaling pathway.
Shi Y; Li J; Chen H; Hu Y; Tang L; Wang Y; Zang X; Ma X; Huang G; Zhou X; Tao M; Lv Z; Chen S; Qiu A; Zhuang S; Liu N
J Pathol; 2022 Oct; 258(2):164-178. PubMed ID: 35792675
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-Inducible Factor-1α Activates the Transforming Growth Factor-β/SMAD3 Pathway in Kidney Tubular Epithelial Cells.
Kushida N; Nomura S; Mimura I; Fujita T; Yamamoto S; Nangaku M; Aburatani H
Am J Nephrol; 2016; 44(4):276-285. PubMed ID: 27607351
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of Murine Diabetic Nephropathy with a SGLT2 Inhibitor Is Associated with Suppressing Abnormal Expression of Hypoxia-Inducible Factors.
Inada A; Inada O; Yasunami Y; Arakawa K; Nabeshima YI; Fukatsu A
Am J Pathol; 2022 Jul; 192(7):1028-1052. PubMed ID: 35460614
[TBL] [Abstract][Full Text] [Related]
14. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.
Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H
Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403
[TBL] [Abstract][Full Text] [Related]
15. HIF-1α mediates Hypoxia-induced epithelial-mesenchymal transition in peritoneal mesothelial cells.
Morishita Y; Ookawara S; Hirahara I; Muto S; Nagata D
Ren Fail; 2016; 38(2):282-9. PubMed ID: 26707495
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of transforming growth factor β1/Smad3 signaling decreases hypoxia-inducible factor-1α protein stability by inducing prolyl hydroxylase 2 expression in human periodontal ligament cells.
Watanabe T; Yasue A; Tanaka E
J Periodontol; 2013 Sep; 84(9):1346-52. PubMed ID: 23088526
[TBL] [Abstract][Full Text] [Related]
17. Effects of tranilast on the epithelial-to-mesenchymal transition in peritoneal mesothelial cells.
Kang SH; Kim SW; Kim KJ; Cho KH; Park JW; Kim CD; Do JY
Kidney Res Clin Pract; 2019 Dec; 38(4):472-480. PubMed ID: 31554027
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin inhibits transforming growth factor β-induced peritoneal angiogenesis by blocking the secondary hypoxic response.
Sekiguchi Y; Zhang J; Patterson S; Liu L; Hamada C; Tomino Y; Margetts PJ
J Cell Mol Med; 2012 Aug; 16(8):1934-45. PubMed ID: 22117756
[TBL] [Abstract][Full Text] [Related]
19. SGLT2 Inhibition by Intraperitoneal Dapagliflozin Mitigates Peritoneal Fibrosis and Ultrafiltration Failure in a Mouse Model of Chronic Peritoneal Exposure to High-Glucose Dialysate.
Balzer MS; Rong S; Nordlohne J; Zemtsovski JD; Schmidt S; Stapel B; Bartosova M; von Vietinghoff S; Haller H; Schmitt CP; Shushakova N
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33228017
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics.
Packer M
Am J Kidney Dis; 2021 Feb; 77(2):280-286. PubMed ID: 32711072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
